Risk of MS relapse after yellow fever vaccination: A self-controlled case series

OBJECTIVE: To determine whether live-attenuated yellow fever vaccine (YFV) was associated with MS relapse, we evaluated the clinical courses of 23 patients in the year before and the year after immunization at the university hospital of Geneva, Switzerland. METHODS: This self-controlled retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Huttner, Angela, Eperon, Gilles, Lascano, Agustina M., Roth, Serge, Schwob, Jean-Marc, Siegrist, Claire-Anne, Lalive, Patrice H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217657/
https://www.ncbi.nlm.nih.gov/pubmed/32358223
http://dx.doi.org/10.1212/NXI.0000000000000726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217657/
https://www.ncbi.nlm.nih.gov/pubmed/32358223
http://dx.doi.org/10.1212/NXI.0000000000000726

Ejemplares similares